Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMM0H9Y)

Drug Name

4,4-Diphenyl-N-(pyridin-3-yl)-butyramide Drug Info

Synonyms

CHEMBL565028; 4,4-Diphenyl-N-(pyridin-3-yl)-butyramide; SCHEMBL4617484; CEQRPUYSSDGEML-UHFFFAOYSA-N; BDBM50297404

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

Molecule(s) Related to This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Soluble epoxide hydrolase (EPHX2)	TT7WVHI	HYES_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule	Molecule Type	Gene Name	Liver	Colon	Kidney	Small Intestine
Soluble epoxide hydrolase (EPHX2)	DTT	EPHX2	8.353	7.227	6.421	8.192

Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease

Discovery agent

ICD Disease Classification

N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Soluble epoxide hydrolase (EPHX2)	DTT	EPHX2	8.78E-01	-0.1	-0.27
Soluble epoxide hydrolase (EPHX2)	DTT	EPHX2	4.40E-02	-0.18	-0.42

Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1	Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase. J Med Chem. 2009 Oct 8;52(19):5880-95.